Velosity buys Lucid Labs to fuse design and manufacturing in medtech
What's the deal? VelosityDealroom has a profile for this one. Try Dealroom →, a Minnesota-based medical device contract manufacturer, has acquired fellow Minnesota firm Lucid LabsDealroom has a profile for this one. Try Dealroom → for an undisclosed sum. The deal, announced in September 2026, creates an integrated platform spanning product design, engineering, and precision manufacturing.
What each side brings: Lucid Labs specialises in product design and development for medical device companies, with expertise in design for manufacturing. That complements Velosity's precision machining and molding operations.
The new hire: Lucid Labs founder and chief executive officer Tim Hillukka joins Velosity as chief innovation officer. The acquisition also adds more than 20 design and development engineers to Velosity's Engineering, Launch and Optimization Lab, deepening its front-end capability.
What's the endgame? Velosity, a portfolio company of Graham PartnersDealroom has a profile for this one. Try Dealroom →, said the combined organisation will serve customers from early-stage design through validation, precision manufacturing, and commercial launch. The goal is to eliminate the design-to-manufacturing handoff that typically delays development.
Why it matters: Velosity said the combination would help customers reduce development timelines and accelerate programmes from prototype to commercial production. It aims to improve launch predictability for medical device clients.
The signal: The deal mirrors a broader shift in contract manufacturing, where full-cycle outsourcing from concept to production is replacing fragmented vendor models. That priority has intensified as device firms face compressed development cycles and evolving regulatory requirements.
Read more: news.outsourceaccelerator.com
Image credit: Generated with Gemini
